What is Juvena Therapeutics worth?
$100.0Mlast known valuation
Juvena Therapeutics last raised $30.5M in its Early Stage VC (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 34 names
- ·Watchlist + deal alerts for Juvena Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Early Stage VC | $30.5M | ▮ | ▮ |
| Feb 2018 | Seed Round | $4.3M | ▮ | ▮ |
How Juvena Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Juvena Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Juvena Therapeutics worth?
- Juvena Therapeutics's last known valuation is $100.0M.
- How much has Juvena Therapeutics raised?
- Juvena Therapeutics has raised $132.2M in total funding across 2 recorded rounds.
- When did Juvena Therapeutics last raise?
- Juvena Therapeutics last raised in Jun 2025 (Early Stage VC), raising $30.5M.